Combination therapy of ustekinumab and immunomodulator for inflammatory bowel disease: concerns about the different results observed between two meta-analyses.

Yoshihara, T; Shinzaki, S; Iijima, H; Tsujii, Y; Hayashi, Y; Takehara, T

Yoshihara, T; Shinzaki, S; Iijima, H; Tsujii, Y; Hayashi, Y; Takehara, T.

Afiliación

Yoshihara T; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
Shinzaki S; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
Iijima H; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo Medical University, Nishinomiya, Japan.
Tsujii Y; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
Hayashi Y; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
Takehara T; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.

J Gastroenterol Hepatol ; 38(5): 830-832, 2023 05.

Article en En | MEDLINE | ID: mdl-36866596

Asunto(s)

Enfermedades Inflamatorias del Intestino; Ustekinumab; Humanos; Ustekinumab/uso terapéutico; Enfermedades Inflamatorias del Intestino/tratamiento farmacológico; Factores Inmunológicos; Terapia Combinada; Resultado del Tratamiento

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Ustekinumab Límite: Humans Idioma: En Revista: J Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google